Literature DB >> 16798038

Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Sanford R Sampson1, Denise R Cooper.   

Abstract

Recent studies implicate specific PKC isoforms in the insulin-signaling cascade. Insulin activates PKCs alpha, betaII, delta and zeta in several cell types. In addition, as will be documented in this review, certain members of the PKC family may also be activated and act upstream of PI3 and MAP kinases. Each of these isoforms has been shown one way or another either to mimic or to modify insulin-stimulated effects in one or all of the insulin-responsive tissues. Moreover, each of the isoforms has been shown to be activated by insulin stimulation or conditions important for effective insulin stimulation. Studies attempting to demonstrate a definitive role for any of the isoforms have been performed on different cells, ranging from appropriate model systems for skeletal muscle, liver and fat, such as primary cultures, and cell lines and even in vivo studies, including transgenic mice with selective deletion of specific PKC isoforms. In addition, studies have been done on certain expression systems such as CHO or HEK293 cells, which are far removed from the tissues themselves and serve mainly as vessels for potential protein-protein interactions. Thus, a clear picture for many of the isoforms remains elusive in spite of over two decades of intensive research. The recent intrusion of transgenic and precise molecular biology technologies into the research armamentarium has opened a wide range of additional possibilities for direct involvement of individual isoforms in the insulin signaling cascade. As we hope to discuss within the context of this review, whereas many of the long sought-after answers to specific questions are not yet clear, major advances have been made in our understanding of precise roles for individual PKC isoforms in mediation of insulin effects. In this review, in which we shall focus our attention on isoforms in the conventional and novel categories, a clear case will be made to show that these isoforms are not only expressed but are importantly involved in regulation of insulin metabolic effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798038      PMCID: PMC2664304          DOI: 10.1016/j.ymgme.2006.04.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  163 in total

1.  Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing.

Authors:  Y Ono; T Kurokawa; T Fujii; K Kawahara; K Igarashi; U Kikkawa; K Ogita; Y Nishizuka
Journal:  FEBS Lett       Date:  1986-10-06       Impact factor: 4.124

2.  Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.

Authors:  L Coussens; P J Parker; L Rhee; T L Yang-Feng; E Chen; M D Waterfield; U Francke; A Ullrich
Journal:  Science       Date:  1986-08-22       Impact factor: 47.728

3.  Phosphorylation of the solubilized insulin receptor by the gene product of the Rous sarcoma virus, pp60src.

Authors:  M F White; D K Werth; I Pastan; C R Kahn
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

Review 4.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

5.  Immunoprecipitation of insulin receptors from cultured human lymphocytes (IM-9 cells) by antibodies to pp60src.

Authors:  N Perrotti; S I Taylor; N D Richert; U R Rapp; I H Pastan; J Roth
Journal:  Science       Date:  1985-02-15       Impact factor: 47.728

6.  Immunodeficiency in protein kinase cbeta-deficient mice.

Authors:  M Leitges; C Schmedt; R Guinamard; J Davoust; S Schaal; S Stabel; A Tarakhovsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

7.  A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells.

Authors:  C E Chalfant; S Ohno; Y Konno; A A Fisher; L D Bisnauth; J E Watson; D R Cooper
Journal:  Mol Endocrinol       Date:  1996-10

8.  Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes.

Authors:  Nabila Aboulaich; Julia P Vainonen; Peter Strålfors; Alexander V Vener
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

9.  Insulin translocates PKC-epsilon and phorbol esters induce and persistently translocate PKC-beta 2 in BC3H-1 myocytes.

Authors:  M L Standaert; A Avignon; T Arnold; S I Saba-Siddique; D R Copper; J Watson; X Zhou; L Galloway; R V Farese
Journal:  Cell Signal       Date:  1996-06       Impact factor: 4.315

10.  Tissue-specific expression of three distinct types of rabbit protein kinase C.

Authors:  S Ohno; H Kawasaki; S Imajoh; K Suzuki; M Inagaki; H Yokokura; T Sakoh; H Hidaka
Journal:  Nature       Date:  1987 Jan 8-14       Impact factor: 49.962

View more
  29 in total

1.  eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser⁵³ is a novel substrate for protein kinase C βI.

Authors:  Manuela Piazzi; Alberto Bavelloni; Irene Faenza; William Blalock; Andrea Urbani; Simona D'Aguanno; Roberta Fiume; Giulia Ramazzotti; Nadir Mario Maraldi; Lucio Cocco
Journal:  Mol Cell Proteomics       Date:  2010-10-05       Impact factor: 5.911

2.  Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.

Authors:  Natasha Case; Jacob Thomas; Buer Sen; Maya Styner; Zhihui Xie; Kornelia Galior; Janet Rubin
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 3.  Activation of protein kinase C isoforms and its impact on diabetic complications.

Authors:  Pedro Geraldes; George L King
Journal:  Circ Res       Date:  2010-04-30       Impact factor: 17.367

4.  PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.

Authors:  Olivier Bezy; Thien T Tran; Jussi Pihlajamäki; Ryo Suzuki; Brice Emanuelli; Jonathan Winnay; Marcelo A Mori; Joel Haas; Sudha B Biddinger; Michael Leitges; Allison B Goldfine; Mary Elizabeth Patti; George L King; C Ronald Kahn
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

Review 5.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

6.  Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restriction.

Authors:  Yuan Wei; Beth Zavilowitz; Lisa M Satlin; Wen-Hui Wang
Journal:  J Biol Chem       Date:  2006-12-28       Impact factor: 5.157

7.  RNAi screening for kinases and phosphatases identifies FoxO regulators.

Authors:  Jaakko Mattila; Jukka Kallijärvi; Oscar Puig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

8.  Opposing actions of insulin and arsenite converge on PKCdelta to alter keratinocyte proliferative potential and differentiation.

Authors:  Tatiana V Reznikova; Marjorie A Phillips; Timothy J Patterson; Robert H Rice
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

9.  Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease.

Authors:  Nicola B Hamilton; David Attwell; Catherine N Hall
Journal:  Front Neuroenergetics       Date:  2010-05-21

Review 10.  Insulin sensitivity: modulation by nutrients and inflammation.

Authors:  Simon Schenk; Maziyar Saberi; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.